AMETOP

This brand name is authorized in Canada, Ireland, New Zealand, United Kingdom, South Africa

Active ingredients

The drug AMETOP contains one active pharmaceutical ingredient (API):

1 Tetracaine
UNII 5NF5D4OPCI - TETRACAINE HYDROCHLORIDE

Tetracaine is a local anaesthetic and is believed to act by blocking nerve conduction mainly by inhibiting sodium ion flux across the axon membrane.

Read about Tetracaine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AMETOP 4% w/w Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D04AB06 Tetracaine D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AB Anesthetics for topical use
Discover more medicines within D04AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02230575
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 37186, 89689, 89690
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7884
Country: ZA Health Products Regulatory Authority Identifier(s): 31/4/0157

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.